Clincosm LogoSign in Get a demo

pancreatic ductal adenocarcinoma

Showing 26 - 50 of 184
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Ductal Adenocarcinoma Trial in New York (VSV-GP154, ATP150, ATP152)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • New York, New York
    NYU Langone Health
May 4, 2023

Healthy Volunteers, Pancreatic Ductal Adenocarcinoma Trial (RAD301 ([68Ga]-Trivehexin))

Not yet recruiting
  • Healthy Volunteers
  • Pancreatic Ductal Adenocarcinoma
  • RAD301 ([68Ga]-Trivehexin)
  • (no location specified)
Mar 22, 2023

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With

Recruiting
  • Pancreatic Cancer
  • +4 more
  • PET Scan
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 10, 2023

Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +14 more
  • ELI-002 7P
  • (no location specified)
Feb 3, 2023

Advances in Imaging to Assess Response in Pancreatic Cancer

Recruiting
  • Pancreatic Ductal Adenocarcinoma
    • Glasgow, United Kingdom
      Beatson West of Scotland Cancer Centre
    Feb 3, 2023

    Pancreatic Cancer Recurrence in the Netherlands

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +3 more
      • Utrecht, Netherlands
        UMC Utrecht
      Feb 1, 2023

      Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)

      Not yet recruiting
      • Non-Small-Cell Lung Carcinoma
      • +2 more
      • Liquid biopsy
      • (no location specified)
      Jan 24, 2023

      Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

      Recruiting
      • Colorectal Carcinoma
      • +21 more
      • Dual X-ray Absorptiometry
      • +2 more
      • Birmingham, Alabama
      • +18 more
      Jan 30, 2023

      Cutaneous Melanoma, Pleural Mesothelioma, HER2 Negative Breast Tumors Trial in Worldwide (SGN-CD228A)

      Active, not recruiting
      • Cutaneous Melanoma
      • +5 more
      • Birmingham, Alabama
      • +13 more
      Jan 23, 2023

      Urothelial Bladder Cancer, Triple-negative Breast Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Tremelimumab

      Active, not recruiting
      Has Results
      • Urothelial Bladder Cancer
      • +2 more
      • Tremelimumab monotherapy
      • +2 more
      • San Francisco, California
      • +13 more
      Jan 20, 2023

      The Pancreas Interception Center for Early Detection,

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +12 more
      • Data collection
      • Tampa, Florida
        Moffitt Cancer Center
      Jan 11, 2023

      Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

      Recruiting
      • Minimal Residual Disease
      • +11 more
      • ELI-002 2P
      • Duarte, California
      • +10 more
      Jan 18, 2023

      Recurrence After Whipple's (RAW) Study

      Active, not recruiting
      • Pancreatic Cancer
      • +13 more
      • Pancreaticoduodenectomy
      • Clayton, Victoria, Australia
      • +28 more
      Jan 13, 2023

      Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma Trial in Netherlands (Leucovorin

      Recruiting
      • Pancreatic Cancer
      • +2 more
      • Leucovorin Calcium
      • +4 more
      • 's-Hertogenbosch, Netherlands
      • +19 more
      Jan 6, 2023

      Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

      Active, not recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +24 more
      • 18F-Fluoromisonidazole
      • +4 more
      • La Jolla, California
      • +15 more
      Jan 3, 2023

      Pancreatic Ductal Adenocarcinoma Trial in Israel, United States (The risk assessment questionnaire, Blood specimens, tumor

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • The risk assessment questionnaire
      • +2 more
      • Basking Ridge, New Jersey
      • +12 more
      Dec 22, 2022

      Pancreatic Ductal Adenocarcinoma Trial in Houston (Pembrolizumab, Folfirinox)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Houston, Texas
      • +1 more
      Dec 15, 2022

      Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Phoenix, Arizona
      • +5 more
      Dec 15, 2022

      Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)

      Active, not recruiting
      Has Results
      • Pancreatic Ductal Adenocarcinoma
      • Saint Louis, Missouri
        Washington University School of Medicine
      Dec 8, 2022

      Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma Trial in Australia (AMP945 ascending doses, AMP945 RP2D)

      Recruiting
      • Pancreatic Cancer
      • +2 more
      • AMP945 ascending doses
      • AMP945 RP2D
      • St Leonards, New South Wales, Australia
      • +6 more
      Dec 7, 2022

      Gastrointestinal Cancers, Cholangiocarcinoma, Gastric Cancer Trial ([18F]FAPI-74 PET/CT)

      Not yet recruiting
      • Gastrointestinal Cancers
      • +5 more
      • [18F]FAPI-74 PET/CT
      • (no location specified)
      Nov 29, 2022

      Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

      Recruiting
      • Pancreatic Adenocarcinoma Metastatic
      • +14 more
      • Boston, Massachusetts
      • +1 more
      Dec 6, 2022

      Pancreatic Ductal Adenocarcinoma Trial in Spain (Gemcitabine, Nab paclitaxel, NLM-001)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Santiago De Compostela, A Coruña, Spain
      • +5 more
      Dec 5, 2022

      Pancreatic Ductal Adenocarcinoma Trial in Durham (HA Chemotherapy)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • HA Chemotherapy
      • Durham, North Carolina
        Duke University Health System
      Nov 22, 2022

      Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Indianapolis (Lonsurf, Gemcitabine, Nab-Paclitaxel)

      Active, not recruiting
      • Pancreatic Cancer
      • Pancreatic Ductal Adenocarcinoma
      • Indianapolis, Indiana
        Indiana University Melvin & Bren Simon Cancer Center
      Nov 29, 2022